🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

European LevFin Wrap — Sanofi’s €10bn debt package, private credit’s retreat

Share

Market Wrap

European LevFin Wrap — Sanofi’s €10bn debt package, private credit’s retreat

Karis Hustad's avatar
Laura Thompson's avatar
  1. Nicolle Liu
  2. +Karis Hustad
  3. + 1 more
7 min read

This is our weekly newsletter on all things leveraged finance, from the latest trends to in-depth coverage, to people moves. Explore all our market wraps here.

At debt market conferences in Amsterdam and Paris this week, the big question on everyone's mind was: When are LBOs and M&A finally coming back? Most seem to think it’ll be Q1 next year, given the geopolitical uncertainty in Europe, the Middle East, and Asia, plus the looming US elections.

The European leveraged finance market had a strong Q3, especially in loans, but the recovery still feels patchy. Even with favorable financing conditions, big M&A deals haven't fully returned to the scene just yet.

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by 9 of the top 10 Investment Banks